
STAAR Surgical Company
- Industry Medical Instruments & Supplies
- Sector Healthcare
- Market Cap
- Earnings
About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
STAA
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- STAAR Surgical GAAP EPS of $0.16 beats by $0.13, revenue of $76.3M beats by $0.51M
- STAAR Surgical Q4 2023 Earnings Preview
- STAAR Surgical collaborates with SharpeVision in the U.S.
- STAAR Surgical forecasts 2024 net sales between $335M - $340M
- It's JPM time! Which medtechs are expected to issue updates this week?
- Staar Surgical projects 15%-20% sales growth in 2024-2026
- STAAR Surgical Non-GAAP EPS of $0.31 beats by $0.13, revenue of $80.3M in-line
- STAAR Surgical Q3 2023 Earnings Preview
- Staar Surgical sees FY26 sales $500M-$550M, operating margin of 12%-16%
- STAAR Surgical gains after shareholder buys additional stake worth $7.87M
- Dolby Laboratories set to join S&P midcap 400; Staar Surgical to join S&P smallcap 600
- Canaccord cuts STAAR to hold, citing US adoption challenges for EVO lenses
- STAAR Surgical misses Q2 top and bottom line estimates; updates FY23 outlook
- STAAR Surgical Q2 2023 Earnings Preview
- STAAR Surgical downgraded to market perform by William Blair
- STAAR Surgical GAAP EPS of $0.05 beats by $0.06, revenue of $73.5M beats by $7.28M
- STAAR Surgical Q1 2023 Earnings Preview
- STAAR Surgical hires Warren Foust as COO
- STAAR Surgical gains after reaffirming sales forecast
- STAAR Surgical falls as 2023 outlook disappoints